Does NIMODIPINE Cause Agranulocytosis? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Agranulocytosis have been filed in association with NIMODIPINE (nimodipine). This represents 1.2% of all adverse event reports for NIMODIPINE.
5
Reports of Agranulocytosis with NIMODIPINE
1.2%
of all NIMODIPINE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Agranulocytosis From NIMODIPINE?
Of the 5 reports, 5 (100.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIMODIPINE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does NIMODIPINE Cause?
Drug ineffective (37)
Hypotension (37)
Cholestasis (31)
Off label use (28)
Intentional overdose (26)
Cardiogenic shock (25)
Toxicity to various agents (25)
Renal failure (24)
Premature baby (23)
Brain injury (22)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which NIMODIPINE Alternatives Have Lower Agranulocytosis Risk?
NIMODIPINE vs NINTEDANIB
NIMODIPINE vs NINTEDANIB ESYLATE
NIMODIPINE vs NIRAPARIB
NIMODIPINE vs NIRMATRELVIR\RITONAVIR
NIMODIPINE vs NIROGACESTAT